Gabapentin and Regadenoson drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabapentin (gabapentin) and Regadenoson (regadenoson). Common drug interactions include nausea among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Regadenoson. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,987 Gabapentin users. Check the latest studies of Gabapentin.

What is Regadenoson?

Regadenoson has active ingredients of regadenoson. eHealthMe is studying from 357 Regadenoson users. Check the latest studies of Regadenoson.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

21 people who take Gabapentin and Regadenoson together, and have interactions are studied.

Gabapentin and Regadenoson drug interactions.

What are the common drug interactions of Gabapentin and Regadenoson, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Depressed level of consciousness
Asthenia (weakness)
Benign intracranial hypertension (benign intracranial hypertension (bih) is a headache syndrome)
Csf pressure increased
Dizziness
Drug level increased
Fatigue (feeling of tiredness)
Flushing (the warm, red condition of human skin)
Headache (pain in head)

male:

Chronic kidney disease
Somnolence (a state of near-sleep, a strong desire for sleep)
Blood glucose increased
Blood lactate dehydrogenase increased
Blood potassium decreased
Chest pain
Confusional state
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Ejection fraction decreased (systolic heart failure)
Haematocrit decreased

What are the common drug interactions of Gabapentin and Regadenoson, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Benign intracranial hypertension (benign intracranial hypertension (bih) is a headache syndrome)
Csf pressure increased
Injury
Migraine (headache)
Nausea (feeling of having an urge to vomit)
Papilloedema (optic disc swelling)
Vision blurred
Visual impairment
Vomiting

40-49:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Nephropathy (damage to or disease of a kidney)

50-59:

Depressed level of consciousness
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Ankle fracture
Anxiety
Chronic kidney disease
Decreased activity
Depression
Emotional distress
Gait disturbance
Intervertebral disc protrusion (spinal disc protrusion)

60+:

Abdominal pain
Alanine aminotransferase increased
Blood potassium decreased
Chest pain
Confusional state
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Ejection fraction decreased (systolic heart failure)
Haematocrit decreased
Haematoma (collection of blood outside the blood vessels)
Haemoglobin decreased

What are the existing conditions these people have? *

Pain: 10 people, 47.62%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 28.57%
High Blood Pressure: 5 people, 23.81%
Diarrhea: 4 people, 19.05%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 19.05%
Constipation: 4 people, 19.05%
Fungal Infection: 3 people, 14.29%
Inflammation: 3 people, 14.29%
Bacterial Infection: 3 people, 14.29%
Chest Pain: 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Regadenoson?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously